Latest Market Study on Pharyngitis Treatment Market
Global Pharyngitis Treatment Market reached US$ 2.3 billion in 2022 and is expected to reach US$ 3.2 billion by 2031, growing with a CAGR of 4.5% during the forecast period 2024-2031.
Pharyngitis is the inflammation of the pharynx, the back part of the throat, which can lead to a sore throat, difficulty swallowing, and sometimes fever. It is commonly caused by viral or bacterial infections, though it can also result from allergies, irritants, or environmental factors. The most common type of pharyngitis is acute pharyngitis, which is typically viral and resolves on its own. Strep throat, a bacterial form of pharyngitis caused by group A Streptococcus bacteria, requires antibiotic treatment to prevent complications.
Pharyngitis can be classified into two main types: viral and bacterial.
- Viral pharyngitis is often caused by viruses such as the common cold, flu, or mononucleosis, and usually resolves without the need for prescription medication.
- Bacterial pharyngitis, primarily caused by strep throat, requires antibiotics to treat the infection and prevent complications such as rheumatic fever or kidney issues.
Treatment for pharyngitis generally involves addressing the underlying cause, managing symptoms, and promoting healing. For viral pharyngitis, over-the-counter pain relievers, throat lozenges, and warm saltwater gargles can help relieve discomfort. For bacterial pharyngitis, antibiotics like penicillin or amoxicillin are prescribed to eliminate the bacteria and reduce symptoms. Home remedies, such as staying hydrated, using humidifiers, and resting the voice, are also recommended to support recovery.
Prevention includes good hygiene practices, avoiding contact with infected individuals, and staying up to date with vaccinations, such as the flu vaccine, to reduce the risk of viral infections.
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/pharyngitis-treatment-market
Market Growth Drivers:
Increasing Demand for Novel Therapeutics is Expected to Drive the Growth of the Pharyngitis Treatment Market
The growing demand for novel therapeutics is expected to drive the global pharyngitis treatment market over the forecast period. While the currently available treatments, especially antibiotics, are widely used, they come with some side effects. New, innovative treatments are being developed to improve patient outcomes with fewer side effects, fueling the demand for more effective and safer options.
For example, on May 16, 2022, Vicks introduced Vicks Tulsi Cough Drops in India. By incorporating Tulsi (Holy Basil), a traditional remedy, the brand aims to offer a product with fewer side effects while making time-honored treatments more accessible and convenient for everyone.
Increasing Demand for OTC Medicines Expected to Drive the Growth of the Pharyngitis Treatment Market
The growing demand for OTC (over-the-counter) medications is expected to drive market growth in the coming years. OTC treatments for pharyngitis, such as throat lozenges, sprays, pain relievers, and other medications, are widely available in hospitals, online pharmacies, retail stores, and supermarkets. These products can be purchased without a prescription or doctor’s visit, offering a convenient solution for quick relief from symptoms.
For example, on November 1, 2021, Mucinex, a trusted brand in the OTC cough and cold category, launched Mucinex InstaSoothe. This new product line includes lozenges and sprays designed to numb, soothe, and relieve sore throat pain. The product range includes Mucinex InstaSoothe Sore Throat + Soothing Comfort Lozenges, Mucinex InstaSoothe Sore Throat + Cough Relief Lozenges, and Mucinex InstaSoothe Sore Throat + Pain Relief Spray.
Market Segments:
- By Disease Type: Acute Pharyngitis, Chronic Pharyngitis
- By Drug Class: Antibiotics, Antiviral Drugs, Corticosteroids, Antifungals, Others
- By Distribution Channel: Hospital Pharmacies , Retail Pharmacies, Online Pharmacies
- By Region: North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Top Key Players:
- Pfizer Inc.
- Novartis
- Amneal Pharmaceuticals LLC
- Kenvue Inc.
- Thornton & Ross Ltd
- Reckitt Benckiser Group Plc
- Honibe
- Prestige Consumer Healthcare Inc.
- Traditional Medicinals, Inc.
- Lozen Pharma Pvt. Ltd
Customize Your Scope: https://www.datamintelligence.com/customize/pharyngitis-treatment-market
Regional Growth
North America Accounted for Approximately 37.7% of the Market Share in 2022, Owing to the Advanced Healthcare Infrastructure and Favourable Reimbursement Policies
North America is expected to dominate the market during the forecast period, thanks to its advanced healthcare infrastructure and favorable reimbursement policies. The U.S. and Canada are known for their well-established healthcare systems, which include a wide range of hospitals, specialty clinics, and ENT (ear, nose, and throat) clinics, all of which offer effective treatments for pharyngitis and quick relief.
Additionally, the high population in the region leads to a higher prevalence of pharyngitis, driving the demand for novel therapeutics. The region’s favorable reimbursement policies further promote the use of innovative treatments, leading to improved patient outcomes.
Key Development
On May 25, 2023, Traditional Medicinals, a leading company known for its high-quality teas, lozenges, and capsules, announced a partnership with Dave Matthews Band by sponsoring REVERB’s Eco-Village during the band’s U.S. summer concert tour. Dave Matthews, a longtime user of Throat Coat tea, has incorporated it into his throat care routine before performing and while connecting with fans onstage. Through this partnership, which aligns with REVERB’s mission to inspire the music community to take meaningful environmental action, Traditional Medicinals aims to bring together people, plants, and the planet for a greater cause.
